Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2026-05-17 @ 2:56 PM
Study NCT ID:
NCT05287360
Status:
COMPLETED
Last Update Posted:
2022-04-18
First Post:
2022-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants
Sponsor:
Elevar Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RM-113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None